Evolution of VHL tumourigenesis in nerve root tissue

Area of Science:

• Neuro-oncology
• Vascular Biology
• Genetics

Background:

• Haemangioblastomas are the primary central nervous system manifestation of von Hippel-Lindau (VHL) disease.
• VHL disease results from germline mutations in the VHL gene.
• Microscopic 'mesenchymal tumourlets' were previously identified in VHL disease spinal cords.

Purpose of the Study:

• To investigate the role of mesenchymal tumourlets as precursors to haemangioblastomas in VHL disease.
• To characterize the cellular and molecular changes within tumourlets during haemangioblastoma development.

Main Methods:

• Histopathological examination of spinal cord tissue from VHL disease patients.
• Immunohistochemical analysis for VHL-deficient cells, HIF-1alpha, HIF-2alpha, CAIX, and VEGF.
• Ultrastructural examination of cellular morphology.

Main Results:

• A subset of mesenchymal tumourlets extends beyond nerve roots, forming proliferative VHL-deficient mesenchyme and haemangioblastomas.
• Tumourlets exhibit VHL-deficient cells with activated HIF-2alpha and HIF-dependent proteins (CAIX, VEGF), promoting angiogenesis.
• HIF-1alpha activation was observed in later stages of tumour progression.
• Ultrastructural analysis showed a gradual transition of cells towards a stromal phenotype.

Conclusions:

• Mesenchymal tumourlets represent true precursor lesions for haemangioblastoma development in VHL disease.
• The evolution of haemangioblastoma involves multiple steps, originating from a pool of precursor lesions.
• Early activation of HIF-2alpha and subsequent angiogenesis are critical events in tumour progression.